NYSE:KEYS

Keysight Technologies, Inc. (NYSE: KEYS) Overview and Financial Performance

Font: Financial Modeling Prep  • Nov 25, 2025

Market Chart

Keysight Technologies, Inc. (NYSE: KEYS) is a prominent player in the electronic equipment manufacturing sector, known for its cutting-edge solutions across communications, electronics, and semiconductor industries. Competing with giants like Tektronix and Rohde & Schwarz, Keysight has recently been spotlighted by Morgan Stanley with a price target of $208, indicating a potential upside of 17.07% from its current price of $177.67.

Keysight's latest fourth-quarter results have shown a positive trajectory for the company. With a 14% increase in orders and revenue growth across all regions, the company is experiencing a resurgence in business momentum. Despite facing temporary margin pressures in the Communications Solutions Group due to tariffs, gross margins are expected to rebound within six months as new contracts begin to reflect these costs.

The surge in demand for AI-driven semiconductors and the stabilization of industrial sectors stand as pivotal growth drivers for Keysight. The company's optimistic projections for its first-quarter revenue and profit, expected to surpass Wall Street estimates, are fueled by robust demand from AI data centers. This positive outlook has led to a 13% increase in Keysight's shares in after-market trading.

Keysight's fourth-quarter earnings report has outperformed analyst expectations, with earnings of $1.91 per share against the forecasted $1.83. The company's quarterly revenue hit $1.42 billion, exceeding the consensus estimate of $1.38 billion, thereby contributing to the stock's upward trajectory.

Currently, KEYS is trading at $177.67, marking a 2.87% increase for the day, which translates to a $4.96 rise. The stock has seen fluctuations between $173.36 and $180.04 during the trading session. Over the past year, KEYS reached a peak of $187.67 and a trough of $121.43. The company boasts a market capitalization of approximately $30.53 billion, with a trading volume of 1,887,408 shares.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.28
50.91%
SBFM
Sunshine Biopharma, Inc.
$0.49
34.47%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.28
-3.10%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.67
-3.31%
NVDA
NVIDIA Corporation
$221.28
-0.98%
WOK
WORK Medical Technology Group Ltd.
$0.15
-21.32%
BITO
ProShares - Bitcoin ETF
$10.64
0.38%
CXAI
CXApp Inc.
$0.23
27.36%
RGTI
Rigetti Computing, Inc.
$21.36
26.51%
NIVF
NewGenIvf Group Limited
$1.19
61.01%